Moderna, Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
Moderna, Inc. is a pharmaceutical and biotechnology company that uses mRNA science to create medicines and vaccines that help the immune system protect against disease. Its research addresses how to protect people from infectious diseases, cancer, autoimmune conditions, and more.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
Moderna, Inc. creates positive Humankind Value on the whole. Considerable positive value is associated with Pharmaceuticals ($29.9 B), Healthcare R&D ($14.5 B), and Economic Value ($3.9 B). Positive value from Pharmaceuticals and Healthcare R&D is linked to an estimate of 850,000 additional years lived by people worldwide. Downsides for this company are associated with Greenhouse Gases (-$660.1 M) and Air Pollution (-$71.8 M). Pharmaceuticals, Healthcare R&D, Economic Value, Greenhouse Gases, and Air Pollution impacts are attached to this company as a result of its direct business activities.